20 Participants Needed

Portable Device for Weight Management

SP
Overseen BySarah Purcell, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of British Columbia
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a portable device designed to aid weight management by measuring metabolism (how the body burns calories) at home. The goal is to determine if the Breezing Portable Indirect Calorimeter helps individuals adhere to personalized weight loss plans and feel satisfied with the process. The trial seeks participants who can easily travel to study visits and exercise moderately less than 300 minutes per week. Participants will use the device weekly for six weeks and provide feedback on their experience. This study includes individuals with or without obesity, as defined by their body mass index (BMI). As an unphased trial, it offers a unique opportunity to contribute to innovative research in weight management technology.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications. However, if you are using regular medication that affects energy balance or sleep, you may not be eligible to participate.

What prior data suggests that this portable device is safe for weight management?

A previous study demonstrated promising safety results for the Breezing Portable Indirect Calorimeter, a device that measures metabolism. It uses a small sensor to measure oxygen and carbon dioxide exhalation. The FDA has approved this device, confirming its safety and effectiveness for similar uses. Participants who used Breezing while following a structured weight management plan adhered to their plan 70% better and lost three times more weight than those who did not use it. No significant negative side effects have been reported, suggesting that Breezing is generally safe and well-tolerated for home metabolism monitoring.12345

Why are researchers excited about this trial?

Researchers are excited about the Breezing Portable Indirect Calorimeter because it offers a new way to manage weight by accurately measuring resting metabolic rate (RMR) on a weekly basis. Unlike traditional methods, which often rely on indirect calculations or expensive lab equipment, this portable device provides an easy and convenient way to assess metabolism in real-time. This could lead to more personalized weight management plans, helping individuals adjust their diet and exercise routines based on precise metabolic data. By offering quick and accessible insights into one's metabolism, it has the potential to revolutionize how people approach weight loss and maintenance.

What evidence suggests that this portable device is effective for weight management?

Research has shown that the Breezing Portable Indirect Calorimeter, which participants in this trial will use, can significantly aid in weight loss. In one study, people using this device lost weight much faster (89%) compared to those who didn't use it (50%). Another study found that those using Breezing, along with a structured weight plan, lost three times more weight and adhered better to their plans than those who didn't use it. The device is simple to use at home, allowing for easy and regular tracking of metabolism, which is how the body uses energy. This suggests that Breezing can be a valuable tool for personalizing weight management and supporting weight loss efforts.34678

Are You a Good Fit for This Trial?

This trial is for men and women aged 19-65 who are either classified as having obesity with a BMI of ≥30kg/m2 or not having obesity with a BMI <29.9kg/m2. Participants must be healthy adults willing to track their metabolism at home using the Breezing device weekly, keep a food diary, and wear an exercise monitor.

Inclusion Criteria

Access to a mobile device (i.e., smartphone or tablet) with reliable Bluetooth and Wi-Fi connection for the 6 week study duration
Ability to attend two in-person sessions at UBCO
Ability and willingness to fast for 12 hours before each study day visit and at least once a week before completing RMR measures using the portable indirect calorimeter
See 7 more

Exclusion Criteria

I have or had major health issues like heart disease, diabetes, cancer, HIV, or others.
Currently or in the past six months: use of regular medication that may affect energy balance, or sleep, regular use of tobacco or nicotine products, starting any new prescription medication within two weeks of the first study day visit or planning to do so during the study, working night shifts or traveling across more than two time zones within two weeks of and throughout the study, history of surgical procedure for weight loss at any time (e.g., gastroplasty, gastric bypass, gastrectomy or partial gastrectomy, adjustable banding, gastric sleeve); history of extensive bowel resection for other reasons, current alcohol or substance abuse (score ≥ 15 on the Alcohol Use Disorders Identification Test (AUDIT) 32, current or past history of eating disorders including anorexia nervosa, bulimia, binge eating disorder (self-report or score >20 on the Eating Attitudes Test - 26 (EATS-26) questionnaire) 33, current symptoms of depression (score ≥ 10 on the Center for Epidemiological Studies Depression Scale, 10-item version (CES-D-10))34, weight loss >5kg in past 12 weeks for any reason, weight loss of >20 kgs in past 3 years for any reason, degree or previous work experience (in the past 10 years) in fields highly related to energy balance (e.g., those exercise or nutrition)

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Assessment

Participants undergo baseline assessments including anthropometric measures, RMR using ParvoMedics and Breezing devices, and psychological and behavioral questionnaires.

1 day
1 visit (in-person)

Treatment

Participants use the Breezing device to measure RMR weekly at home for six weeks, complete weekly Qualtrics surveys, and use activPAL activity monitors.

6 weeks
6 visits (virtual)

Follow-up

Participants undergo follow-up assessments including body composition using DEXA, repeat RMR measurements, and user satisfaction interviews.

1 day
1 visit (in-person)

What Are the Treatments Tested in This Trial?

Interventions

  • Breezing Portable Indirect Calorimeter
Trial Overview The study tests how feasible and satisfying it is for participants to use the Breezing Portable Indirect Calorimeter at home over six weeks to measure their resting metabolic rate (RMR). It also examines how this self-monitoring relates to diet, physical activity, and psychological factors.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: Breezing Portable Indirect CalorimeterExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of British Columbia

Lead Sponsor

Trials
1,506
Recruited
2,528,000+

Published Research Related to This Trial

The Q-NRG® indirect calorimeter demonstrated high accuracy in measuring oxygen consumption (VO2), carbon dioxide production (VCO2), and energy expenditure (EE), with measurement errors of less than 1% in vitro and minimal differences compared to mass spectrometry in vivo.
The device showed excellent intra- and inter-unit precision, with coefficients of variation (CV%) of ≤1% for VO2 and EE, indicating it is a reliable tool for real-time energy expenditure measurement in clinical settings.
Evaluation of the accuracy and precision of a new generation indirect calorimeter in canopy dilution mode.Delsoglio, M., Dupertuis, YM., Oshima, T., et al.[2021]
Indirect calorimetry is a valuable tool for accurately assessing resting energy expenditure, which helps in designing personalized nutritional regimens for patients based on their specific clinical conditions.
By controlling the testing environment and accounting for clinical factors, indirect calorimetry can reduce complications from overfeeding and lead to cost savings by avoiding unnecessary nutritional support.
Use of indirect calorimetry in clinical nutrition.McClave, SA., Snider, HL.[2017]
Indirect calorimetry (IC) significantly improves energy delivery in critically ill patients, leading to a reduction in short-term mortality compared to traditional predictive equations, based on a meta-analysis of 8 randomized controlled trials involving 991 adults.
The use of IC-guided nutrition did not increase the duration of mechanical ventilation or length of ICU and hospital stays, and the rate of adverse events was similar between IC and control groups, suggesting it is a safe and effective approach.
Energy delivery guided by indirect calorimetry in critically ill patients: a systematic review and meta-analysis.Duan, JY., Zheng, WH., Zhou, H., et al.[2021]

Citations

Study of the Effect of Mobile Indirect Calorimeter on Weight ...The results indicated that the use of the mobile indirect calorimeter in the IG had positive effects on weight loss rate (89% in the IG vs. 50% in the CG, p = ...
Study of the Effect of Mobile Indirect Calorimeter on Weight ...The results indicated that the use of the mobile indirect calorimeter in the IG had positive effects on weight loss rate (89% in the IG vs. 50% ...
Gold Standard - Indirect CalorimetryIndividuals using Breezing, while following a structured weight management plan, showed 70% greater adherence and 3x greater weight loss compared to a control ...
Comparative study of a novel portable indirect calorimeter ...Results were recorded and analyzed for variability. The pilot study demonstrated the advantage of Breezing Med device to be easy-to-use at home by lay people, ...
Feasibility and user acceptability of Breezing™, a mobile ...The purpose of this study was to examine the feasibility and user acceptability of Breezing™ to assess REE in pregnant women with overweight or obesity ...
6.breezing.combreezing.com/
Breezing: Metabolic Rate Analysis Device | Respiratory ...Through indirect calorimetry using a single stamp-sized sensor cartridge, Breezing precisely measures both oxygen (O2) and carbon dioxide (CO2). Breezing's FDA- ...
K200076 - Roberta (Bobbi) Druyor-Sanchez Regulatory ...Breezing MedTM is a stand-alone and fully integrated mask-like wearable metabolic analyzer based on the principle of indirect calorimetry, which ...
Clinical evaluation of the new indirect calorimeter in ...The primary objective was to assess the minimum time required to perform REE measurement in canopy and face mask mode with Q-NRG® compared to Quark RMR® (COSMED ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security